Table 1.

Demographics for individuals with ME/CFS taking aripiprazole (Abilify)

Demographics	Responders	Non-responders	Total
Individuals with ME/CFS, n (%)	75 (74.3%)	26 (25.8%)	101 (100%)
Mean age, years (range)	48.9 (18–76)	52.2 (28–84)	49.7 (18–84)
Duration of illness, years (range)	12.6 (2–54)	15.8 (1–44)	13.4 (1–54)
Female, n (%)	52 (69.4%)	16 (61.5%)	68 (67%)
Male, n (%)	23 (30.6%)	10 (38.5%)	33 (33%)
Aripiprazole dose, mg (range)	1.2 (0.25–2.0)	0.7 (0–2.0)	1.1 (0–2.0)
Duration of treatment, average months (range)	8.0 (0–17)	7.1 (0–13)	7.8 (0–17)
Concurrent antidepressant use	46,175 (61.3%)*	11/26 (42.3%)*	57/101 (56.4%)

^*p = 0.145